BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24687509)

  • 1. Pharmacokinetic interactions between primaquine and chloroquine.
    Pukrittayakamee S; Tarning J; Jittamala P; Charunwatthana P; Lawpoolsri S; Lee SJ; Hanpithakpong W; Hanboonkunupakarn B; Day NP; Ashley EA; White NJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3354-9. PubMed ID: 24687509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of chloroquine and primaquine in healthy volunteers.
    Daher A; Pinto DP; da Fonseca LB; Pereira HM; da Silva DMD; da Silva LSFV; Esteves AL; Soares Medeiros JJ; Mendonça JS
    Malar J; 2022 Jan; 21(1):16. PubMed ID: 34998391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
    Jittamala P; Pukrittayakamee S; Ashley EA; Nosten F; Hanboonkunupakarn B; Lee SJ; Thana P; Chairat K; Blessborn D; Panapipat S; White NJ; Day NP; Tarning J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):505-13. PubMed ID: 25385096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
    Chu CS; Watson JA; Phyo AP; Win HH; Yotyingaphiram W; Thinraow S; Soe NL; Aung AA; Wilaisrisak P; Kraft K; Imwong M; Hanpithakpong W; Blessborn D; Tarning J; Proux S; Ling C; Nosten FH; White NJ
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0130221. PubMed ID: 34398667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
    Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
    Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
    Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.
    Höglund R; Moussavi Y; Ruengweerayut R; Cheomung A; Äbelö A; Na-Bangchang K
    Malar J; 2016 Feb; 15():129. PubMed ID: 26928448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
    Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
    Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primaquine in Plasma and Methemoglobinemia in Patients with Malaria Due to
    Vieira JL; Ferreira MES; Ferreira MVD; Gomes MM
    Am J Trop Med Hyg; 2017 May; 96(5):1171-1175. PubMed ID: 28440745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal primaquine use for radical cure of Plasmodium vivax and Plasmodium ovale malaria in Japanese travelers--A retrospective analysis.
    Shimizu S; Kikuchi T; Koga M; Kato Y; Matsuoka H; Maruyama H; Kimura M;
    Travel Med Infect Dis; 2015; 13(3):235-40. PubMed ID: 25482427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium vivax Volunteer Infection Study.
    Abd-Rahman AN; Marquart L; Gobeau N; Kümmel A; Simpson JA; Chalon S; Möhrle JJ; McCarthy JS
    Clin Pharmacol Ther; 2020 Nov; 108(5):1055-1066. PubMed ID: 32415986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
    Baird JK; Basri H; Subianto B; Fryauff DJ; McElroy PD; Leksana B; Richie TL; Masbar S; Wignall FS; Hoffman SL
    J Infect Dis; 1995 Jun; 171(6):1678-82. PubMed ID: 7769318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.